Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
1.7K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

5.7K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

6.4K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
The Ras Gene02:38

The Ras Gene

7.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

9.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of MCL-1 expression in colorectal cancer.

International journal of cancer·2024
Same author

Resveratrol and Female Fertility: A Systematic Review.

International journal of molecular sciences·2024
Same author

Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.

Cancer discovery·2024
Same author

CRISPR screens in 3D tumourspheres identified miR-4787-3p as a transcriptional start site miRNA essential for breast tumour-initiating cell growth.

Communications biology·2024
Same author

Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2024
Same author

Prospectively Defined Clusters of Coronavirus Disease 2019 Sequelae.

The Journal of infectious diseases·2024

Related Experiment Video

Updated: Apr 5, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

13.2K

The role of Rho-associated coiled-coil kinases (ROCK) in cancer.

Laura Zafrany1,2, Rui Wu3, Amy Melsaether3

  • 1Department of Biochemical Engineering, University College London, London, UK. laura.zafrany.23@ucl.ac.uk.

Oncogene
|April 3, 2026
PubMed
Summary

Rho-associated coiled-coil kinases (ROCKs) are crucial for cell functions and implicated in cancer. This review highlights ROCK2

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.6K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

920

Related Experiment Videos

Last Updated: Apr 5, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

13.2K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.6K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

920

Area of Science:

  • Cell Biology
  • Molecular Oncology

Background:

  • Rho-associated coiled-coil kinases (ROCKs) are key regulators of the actin cytoskeleton, influencing cell contraction, migration, and adhesion.
  • Two isoforms, ROCK1 and ROCK2, possess overlapping functions, with their roles being context-dependent on cell type and microenvironment.
  • ROCKs are increasingly linked to various diseases, notably cancer, where their overexpression correlates with progression, metastasis, and resistance to therapy.

Purpose of the Study:

  • To review the specific role of Rho-associated coiled-coil kinases (ROCKs), with a focus on ROCK2, in the development of cancer (carcinogenesis).
  • To elucidate the mechanisms by which the RhoA/ROCK2 signaling pathway contributes to oncogenic processes.

Main Methods:

  • Literature review of existing research on ROCKs and their involvement in cancer.
  • Analysis of studies detailing the molecular mechanisms of ROCK2 in cellular processes relevant to cancer.

Main Results:

  • ROCK2 overexpression is associated with enhanced cancer progression, metastasis, and therapeutic resistance.
  • Inhibition of ROCK2 has shown significant tumor inhibitory effects.
  • The RhoA/ROCK2 pathway regulates cytoskeletal organization, cell motility, cell cycle progression, epithelial-mesenchymal transition (EMT), vascular mimicry (VM), and fibrosis, all critical in carcinogenesis.

Conclusions:

  • ROCK2 plays a significant role in carcinogenesis through its regulation of fundamental cellular processes and crosstalk with other signaling pathways.
  • Targeting ROCK2 presents a promising therapeutic strategy for cancer treatment due to its demonstrated tumor inhibitory potential.